• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤病学中的柳氮磺胺吡啶:一种尚未充分探索但具有广泛治疗潜力的药物。

Sulfasalazine in dermatology: A lesser explored drug with broad therapeutic potential.

作者信息

Mushtaq Sabha, Sarkar Rashmi

机构信息

Department of Dermatology, Venereology & Leprology, Government Medical College, Jammu, Jammu & Kashmir, India.

Department of Dermatology, Venereology & Leprology, Maulana Azad Medical College, New Delhi, India.

出版信息

Int J Womens Dermatol. 2020 Feb 13;6(3):191-198. doi: 10.1016/j.ijwd.2020.01.009. eCollection 2020 Jun.

DOI:10.1016/j.ijwd.2020.01.009
PMID:32637543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7330441/
Abstract

Sulfasalazine is an aminosalicylate primarily used in the treatment of rheumatoid arthritis and ulcerative colitis. Its immunomodulatory, anti-inflammatory, and antiproliferative properties make it a potential therapeutic option for various dermatological disorders. Owing to its wide range of effects, it is often used off-label in dermatological diseases, such as alopecia areata, psoriasis and psoriatic arthritis, lichen planus, and pemphigus. However, the level of evidence supporting its efficacy and safety in dermatology is limited. More research is needed to uncover the full potential of sulfasalazine in dermatology. The present article is a detailed review of the pharmacology, modes of action, side effects, and contraindications of sulfasalazine, along with an up-to-date review of the evidence underlying its use in various dermatological conditions.

摘要

柳氮磺胺吡啶是一种氨基水杨酸酯,主要用于治疗类风湿性关节炎和溃疡性结肠炎。其免疫调节、抗炎和抗增殖特性使其成为各种皮肤病潜在的治疗选择。由于其作用广泛,它常被用于治疗斑秃、银屑病和银屑病关节炎、扁平苔藓和天疱疮等皮肤病,但未按药品说明书用药。然而,支持其在皮肤科疗效和安全性的证据水平有限。需要更多研究来揭示柳氮磺胺吡啶在皮肤科的全部潜力。本文详细综述了柳氮磺胺吡啶的药理学、作用方式、副作用和禁忌证,以及对其在各种皮肤病中应用证据的最新综述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b721/7330441/ea739f1ca8aa/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b721/7330441/ea739f1ca8aa/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b721/7330441/ea739f1ca8aa/gr1.jpg

相似文献

1
Sulfasalazine in dermatology: A lesser explored drug with broad therapeutic potential.皮肤病学中的柳氮磺胺吡啶:一种尚未充分探索但具有广泛治疗潜力的药物。
Int J Womens Dermatol. 2020 Feb 13;6(3):191-198. doi: 10.1016/j.ijwd.2020.01.009. eCollection 2020 Jun.
2
Off-label studies on tofacitinib in dermatology: a review.托法替布在皮肤科的非标签研究综述
J Dermatolog Treat. 2021 Jun;32(4):399-409. doi: 10.1080/09546634.2019.1673877. Epub 2019 Oct 3.
3
Evolving utility of apremilast in dermatological disorders for off-label indications.阿普司特在皮肤科疾病中的应用不断发展,用于治疗标签外适应证。
Clin Exp Dermatol. 2022 Dec;47(12):2136-2149. doi: 10.1111/ced.15377. Epub 2022 Oct 8.
4
Sulfasalazine for alopecia areata.柳氮磺胺吡啶用于斑秃。
J Am Acad Dermatol. 2002 Apr;46(4):541-4. doi: 10.1067/mjd.2002.119671.
5
Off-Label Use of Baricitinib in Dermatology.巴瑞替尼在皮肤科的超适应证使用。
J Drugs Dermatol. 2023 Aug 1;22(8):795-801. doi: 10.36849/jdd.7360.
6
Cyclosporin in dermatology: A practical compendium.皮肤病学中的环孢素:实用概要。
Dermatol Ther. 2020 Nov;33(6):e13934. doi: 10.1111/dth.13934. Epub 2020 Sep 6.
7
Role of Cyclosporine (CsA) in Immuno-dermatological Conditions.环孢素(CsA)在免疫性皮肤病中的作用。
Indian Dermatol Online J. 2022 Sep 5;13(5):585-599. doi: 10.4103/idoj.idoj_189_22. eCollection 2022 Sep-Oct.
8
[Dermatology. New uses for JAK inhibitors in dermatology: a panacea, but at what price?].[皮肤病学。JAK抑制剂在皮肤病学中的新用途:万灵药,但代价几何?]
Rev Med Suisse. 2024 Jan 31;20(859):241-246. doi: 10.53738/REVMED.2024.20.859.241.
9
Off-label studies on apremilast in dermatology: a review.阿普斯特在皮肤科的超适应证研究:综述。
J Dermatolog Treat. 2020 Mar;31(2):131-140. doi: 10.1080/09546634.2019.1589641. Epub 2019 Apr 2.
10
Dermoscopy in General Dermatology: A Practical Overview.普通皮肤科中的皮肤镜检查:实用概述
Dermatol Ther (Heidelb). 2016 Dec;6(4):471-507. doi: 10.1007/s13555-016-0141-6. Epub 2016 Sep 9.

引用本文的文献

1
Sulfasalazine induces ferroptosis in osteosarcomas by regulating Nrf2/SLC7A11/GPX4 signaling axis.柳氮磺胺吡啶通过调节Nrf2/SLC7A11/GPX4信号轴诱导骨肉瘤细胞发生铁死亡。
Sci Rep. 2025 Aug 18;15(1):30197. doi: 10.1038/s41598-025-13324-5.
2
Multiscale metal-based nanocomposites for bone and joint disease therapies.用于骨与关节疾病治疗的多尺度金属基纳米复合材料。
Mater Today Bio. 2025 Apr 17;32:101773. doi: 10.1016/j.mtbio.2025.101773. eCollection 2025 Jun.
3
Off-Label Treatment in Inflammatory Skin Diseases-European Point of View.

本文引用的文献

1
Low-dose sulfasalazine in a case of pyodermatitis-pyostomatitis vegetans.
J Am Acad Dermatol. 2020 May;82(5):e149-e150. doi: 10.1016/j.jaad.2018.10.020. Epub 2018 Oct 21.
2
A case of acrodermatitis continua of Hallopeau (ACH) successfully treated with sulfasalazine.1例用柳氮磺胺吡啶成功治疗的Hallopeau连续性肢端皮炎(ACH)。
Dermatol Ther. 2018 May;31(3):e12595. doi: 10.1111/dth.12596. Epub 2018 Apr 25.
3
Complete resolution of erythema elevatum diutinum using oral sulfasalazine.使用口服柳氮磺胺吡啶使持久性隆起性红斑完全消退。
炎症性皮肤病的非标签治疗——欧洲视角
J Clin Med. 2025 Mar 30;14(7):2376. doi: 10.3390/jcm14072376.
4
Development and Evaluation of Hydrogel-Based Sulfasalazine-Loaded Nanosponges for Enhanced Topical Psoriasis Therapy.用于增强局部银屑病治疗的水凝胶基载柳氮磺胺吡啶纳米海绵的研制与评价
Pharmaceuticals (Basel). 2025 Mar 10;18(3):391. doi: 10.3390/ph18030391.
5
Bioinformatic analysis of ferroptosis related biomarkers and potential therapeutic targets in vitiligo.白癜风中与铁死亡相关生物标志物及潜在治疗靶点的生物信息学分析
Sci Rep. 2025 Jan 15;15(1):2035. doi: 10.1038/s41598-025-86061-4.
6
Sulfasalazine-Induced Nail Changes: A Unique Clinical Observation.柳氮磺胺吡啶所致指甲改变:一项独特的临床观察
Dermatol Pract Concept. 2024 Oct 30;14(4):e2024253. doi: 10.5826/dpc.1404a253.
7
Erythema Elevatum diutinum - a long-term case series of 10 patients.
Arch Dermatol Res. 2024 Dec 9;317(1):88. doi: 10.1007/s00403-024-03643-4.
8
Synthetic Approaches, Properties, and Applications of Acylals in Preparative and Medicinal Chemistry.酰基试剂在制备和药物化学中的合成方法、性质和应用
Molecules. 2024 Sep 19;29(18):4451. doi: 10.3390/molecules29184451.
9
Transcriptomics- and Genomics-Guided Drug Repurposing for the Treatment of Vesicular Hand Eczema.转录组学和基因组学指导下的药物重新利用治疗水疱型手部湿疹
Pharmaceutics. 2024 Mar 30;16(4):476. doi: 10.3390/pharmaceutics16040476.
10
Evaluating the Clinical Utility of Sulfasalazine in the Treatment of Pyoderma Gangrenosum: A Systematic Review.评估柳氮磺胺吡啶治疗坏疽性脓皮病的临床效用:一项系统评价。
J Cutan Med Surg. 2024 May-Jun;28(3):289-291. doi: 10.1177/12034754241238713. Epub 2024 Mar 10.
Dermatol Online J. 2017 Oct 15;23(10):13030/qt8267v8v9.
4
Hair diseases: a big problem on a small surface.毛发疾病:小面积上的大问题。
Postepy Dermatol Alergol. 2016 Oct;33(5):317-322. doi: 10.5114/ada.2016.62834. Epub 2016 Oct 21.
5
Sulfasalazine and pentoxifylline, a new adjuvant in young pemphigus patients: A pilot study.
Indian J Dermatol Venereol Leprol. 2015 Nov-Dec;81(6):640-2. doi: 10.4103/0378-6323.168341.
6
Topical sulfasalazine for unresponsive oral lichen planus.外用柳氮磺胺吡啶治疗反应性口腔扁平苔藓。
Quintessence Int. 2016 Apr;47(4):319-27. doi: 10.3290/j.qi.a34974.
7
Efficacy and safety of sulfasalazine in patients with chronic idiopathic urticaria.柳氮磺胺吡啶治疗慢性特发性荨麻疹的疗效和安全性。
Ann Allergy Asthma Immunol. 2014 Jan;112(1):64-70. doi: 10.1016/j.anai.2013.09.028. Epub 2013 Nov 9.
8
Current medical treatment of ocular mucous membrane pemphigoid.眼黏膜类天疱疮的当前医学治疗。
Ocul Surf. 2013 Oct;11(4):259-66. doi: 10.1016/j.jtos.2013.02.003. Epub 2013 Jul 9.
9
Sulfasalazine induced lichen planus in a patient of rheumatoid arthritis.
Indian J Dermatol Venereol Leprol. 2013 Jul-Aug;79(4):541-4. doi: 10.4103/0378-6323.113103.
10
Pyoderma gangrenosum: An update.坏疽性脓皮病:最新进展
Indian Dermatol Online J. 2012 Jan;3(1):7-13. doi: 10.4103/2229-5178.93482.